Texas Instruments Incorporated

(NASDAQ Global Select)
Back to all articles
Somewhat Bullish +30

Should You Buy Texas Instruments Stock Now Or Wait?

Financial outlook AI-generated analysis

πŸ“ˆ Texas Instruments stock has returned 91.4% over the past twelve months, trading at a forward P/E multiple of 40.0x near its highest close of the year.

πŸ’° The company reported an operating margin of 41.1% for the twelve months to September 2026, with quarterly margins climbing from 34% in fiscal Q4 2025 to 47.6% in fiscal Q3 2026.

πŸš€ Revenue reached $6.06 billion in fiscal Q3 2026, up 27.7% year-over-year, driven by data center sales growth of approximately 95%.

🏭 Industrial sales surpassed their prior fiscal Q3 2022 peak during fiscal Q3 2026, marking a key milestone in the cyclical recovery.

πŸ“… Texas Instruments guided fiscal Q4 2026 revenue between $5.8 billion and $6.3 billion, with a midpoint of $6.05 billion.

πŸ‘€ Analysts expect revenue of $6.11 billion for fiscal Q4 2026, which sits slightly above the company's guidance midpoint.

πŸ“‰ The stock rose 17.3% after an April 2026 earnings beat but fell 13.6% after a July 2025 miss, showing volatility around reports.

⚠️ Management stated there is no slowdown in data center demand, which remains a key growth driver for the company.

πŸ“Š The upcoming fiscal Q4 2026 results are expected to be reported in January 2027, with revenue being the primary metric to watch.

Bullish Signals
  • Texas Instruments achieved a significant milestone where industrial sales surpassed their prior fiscal Q3 2022 peak during fiscal Q3 2026.
  • Data center sales grew approximately 95% year-over-year in fiscal Q3 2026, contributing to a 27.7% total revenue increase.
  • The company reported an operating margin of 41.1% for the twelve months to September 2026, with quarterly margins climbing rapidly from 34% to 47.6%.
  • Management confirmed there is no slowdown in data center demand, which continues to drive strong revenue growth.
  • The stock has demonstrated resilience with a 17.3% rise following the April 2026 earnings report.
Risk Factors
  • Texas Instruments trades at a forward P/E multiple of 40.0x, which is higher than at 36 of the 40 quarter ends since late 2016.
  • The current valuation appears to assume continued margin recovery toward 2022 levels rather than pricing in the margins already reported.
  • Analysts expect revenue of $6.11 billion for fiscal Q4 2026, which is only slightly above the company's guidance midpoint, suggesting limited upside surprise potential.
  • The stock was almost unchanged by the second close following the October 21 report, trading at $284.69 against $284.65.
Full Analysis
Texas Instruments (TXN) stock has surged 91.4% over the past twelve months, trading at a forward price-to-earnings multiple of 40.0x, significantly higher than the S&P 500 average and near its highest level since late 2016. The company reported an operating margin of 41.1% for the twelve months ending September 2026, with quarterly margins climbing rapidly from 34% in fiscal Q4 2025 to 47.6% in fiscal Q3 2026. The recent financial performance was driven by a 27.7% year-over-year increase in revenue, reaching $6.06 billion in fiscal Q3 2026, with data center sales surging approximately 95%. Management highlighted that industrial sales have surpassed their prior peak from fiscal Q3 2022, signaling a key milestone in the broader cyclical recovery for the semiconductor manufacturer. Looking ahead to fiscal Q4 2026, Texas Instruments has guided revenue between $5.8 billion and $6.3 billion, with a midpoint of $6.05 billion that aligns closely with the previous quarter's reported results. Analysts expect revenue of $6.11 billion for the upcoming quarter, suggesting investors are pricing in continued stability rather than significant acceleration, as management notes no slowdown in data center demand. The stock has shown volatility following earnings reports, rising 17.3% after an April 2026 beat but falling 13.6% after a July 2025 miss, and recently trading almost unchanged at $284.69 following the October 21 report. The high valuation implies the market is paying for future margin expansion toward 2022 levels rather than current reported figures, making the upcoming January 2027 revenue report a critical test of whether sales can continue to rise from fiscal Q3 levels.